Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
151 studies found for:    "Celiac Disease"
Show Display Options
Rank Status Study
1 Recruiting Celiac Disease Database
Condition: Celiac Disease
Intervention:
2 Completed Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease
Condition: Celiac Disease
Interventions: Drug: AT-1001;   Drug: placebo
3 Completed Oral AGY for Celiac Disease
Condition: Celiac Disease
Intervention: Other: AGY
4 Completed A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease
Condition: Celiac Disease
Intervention: Drug: 4 dose levels of ALV003
5 Completed Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal
Condition: Celiac Disease
Interventions: Drug: ALV003;   Drug: Placebo
6 Completed Saliva Composition and Oral Hygiene in Children With Celiac Disease Before and After the Change in Diet
Condition: Celiac Disease
Intervention:
7 Completed Effect of Addition of Short Course of Prednisolone to Gluten Free Diet in Naive Celiac Disease Patients
Condition: Celiac Disease
Interventions: Drug: Prednisolone and Gluten free diet;   Behavioral: Gluten free diet
8 Unknown  Celiac Disease Prevention
Condition: Celiac Disease
Intervention: Other: Optimal gluten introduction
9 Enrolling by invitation Immune Response in Celiac Disease on In-vitro Gluten Challenge
Condition: Celiac Disease
Intervention:
10 Completed Clinical Trial on the Effects of Bifidobacterium Infantis in Active Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Probiotic
11 Completed Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide acetate (AT1001);   Drug: Placebo
12 Completed
Has Results
Desensitising Celiac Disease Patients With the Human Hookworm
Condition: Celiac Disease
Intervention: Biological: Necator americanus
13 Not yet recruiting Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease
Condition: Celiac Disease
Intervention:
14 Completed Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Condition: Celiac Disease
Intervention:
15 Completed Safety and Efficacy of ALV003 for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Biological: ALV003;   Biological: ALV003 placebo
16 Active, not recruiting Screen-detected Coeliac Disease, a Population Based Study
Condition: Celiac Disease
Intervention: Other: Gluten-free diet
17 Unknown  Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
Condition: Celiac Disease
Interventions: Drug: ALV003;   Drug: placebo
18 Completed Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Biological: ALV003;   Biological: ALV003 placebo
19 Completed A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide Acetate 0.5 mg;   Drug: Larazotide Acetate 1 mg;   Drug: Larazotide Acetate 2 mg;   Drug: placebo
20 Recruiting Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
Condition: Celiac Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.